Literature DB >> 1428759

Argyrophylic nucleolar organiser regions (AgNOR's) as a prognostic indicator in breast carcinoma.

D J Hehir1, K J Cronin, P A Dervan, A McCann, D N Carney, W P Hederman, S J Heffernan.   

Abstract

Silver staining nucleolar organiser regions (AgNOR's) were determined in archival histological specimens of breast carcinoma. Representative samples from forty-eight female patients were counted manually for AgNOR's--median 3.85 (range 1.1-10.2 AgNOR's per cell). Taking the median value of 3.85 as a cutoff, the patients were divided into two groups: A = Those with AgNOR counts > 3.85; B = Patients with AgNOR counts < or = 3.85. The 5 year survival was 21% in group A and 85% in group B (p < 0.001). There was no significant correlation between AgNOR's and tumour size, lymph node status, tumour grade, menopausal status and oestrogen receptors. We conclude that nucleolar organiser regions may be useful as a prognostic indicator in breast carcinoma especially in patients in whom other prognostic information is unavailable.

Entities:  

Mesh:

Year:  1992        PMID: 1428759     DOI: 10.1007/bf02983761

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  19 in total

1.  Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level.

Authors:  D Ploton; M Menager; P Jeannesson; G Himber; F Pigeon; J J Adnet
Journal:  Histochem J       Date:  1986-01

2.  Nucleolar organiser regions in fibrous proliferations of childhood and infantile fibrosarcoma.

Authors:  M J Egan; F Raafat; J Crocker; K Smith
Journal:  J Clin Pathol       Date:  1988-01       Impact factor: 3.411

3.  Are AgNORs useful in distinguishing follicular hyperplasia from follicular lymphoma?

Authors:  K Cronin; B M Loftus; P A Dervan
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

4.  Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry.

Authors:  D D Giri; J F Nottingham; J Lawry; S A Dundas; J C Underwood
Journal:  J Pathol       Date:  1989-04       Impact factor: 7.996

Review 5.  Nucleolus organizer regions and nucleoli.

Authors:  H G Schwarzacher; F Wachtler
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

6.  Factors influencing local recurrence after excision and radiotherapy for primary breast cancer.

Authors:  A P Locker; I O Ellis; D A Morgan; C W Elston; A Mitchell; R W Blamey
Journal:  Br J Surg       Date:  1989-09       Impact factor: 6.939

7.  Breast carcinoma kinetics. Argyrophilic nucleolar organizer region counts correlate with Ki67 scores.

Authors:  P A Dervan; L G Gilmartin; B M Loftus; D N Carney
Journal:  Am J Clin Pathol       Date:  1989-10       Impact factor: 2.493

8.  Predictors of recurrence and survival of patients with breast cancer.

Authors:  J Russo; J Frederick; H E Ownby; G Fine; M Hussain; H I Krickstein; T O Robbins; B Rosenberg
Journal:  Am J Clin Pathol       Date:  1987-08       Impact factor: 2.493

9.  Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update.

Authors:  B Fisher; M Bauer; D L Wickerham; C K Redmond; E R Fisher; A B Cruz; R Foster; B Gardner; H Lerner; R Margolese
Journal:  Cancer       Date:  1983-11-01       Impact factor: 6.860

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  1 in total

1.  Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long-term survival.

Authors:  D Ofner; B Bier; S Heinrichs; M Berghorn; M Dünser; H A Hagemann; D Langer; W Böcker; K W Schmid
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.